Delivery Order SPE2DB22D2006-SPE2DB24FW0HB
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a delivery order contract worth $6,027.24 for the supply of Forteo 600 mcg/2.4 mL pen injections. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,772.06 firm fixed price delivery order is for the supply of Forteo 600 mcg/2.4 ml pen injections. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,772.06 firm fixed-price delivery order is for the supply of 600 mcg/2.4 ml Forteo pen injections. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Forteo 600 mcg/2.4 ml pen injections. The contract has a ceiling value of $4,376.93 and a completion date of July 10, 2024. The contract is a firm fixed price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is one of the largest pharmaceutical distribution...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,316.18 for the pharmaceutical product Forteo 600 mcg/2.4 mL pen injection. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 20, 2023. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order for Forteo 600 mcg/2.4 mL pen injections. The award has a ceiling value of $4,985.51 and a period of performance through April 4, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to the Department...
- This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Forteo 600 MCG/2.4 ML pen injections. The award has a ceiling value of $10,632.36 and a completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on this firm fixed price contract, which is not set aside for any specific business designation. In addition to this contract,...
- This federal contract award, valued at $16,257.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply the medication Forteo (teriparatide) 560 mcg/2.24 ml pen injection. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC...
- This federal contract award, valued at $1,136.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the supply of FORTEO 600 MCG/2.4 ML PEN INJ 2.4ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Forteo 600 mcg/2.4 ml pen injections in 2.4 ml doses. The $4,028.53 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 through December 31, 2025, which allows DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for military treatment programs and...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW0HBDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Forteo (teriparatide) 600 mcg/2.4 ml pen injection. The contract has a ceiling value of $5,316.18 and is a firm fixed-price delivery order with a completion date of May 14, 2024. Amerisourcebergen is a subsidiary of Cencora, Inc. and this award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Additionally, Amerisourcebergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 5/13/24 |